{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T01:58:52Z","timestamp":1776045532805,"version":"3.50.1"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,10,16]],"date-time":"2014-10-16T00:00:00Z","timestamp":1413417600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s10555-014-9520-6","type":"journal-article","created":{"date-parts":[[2014,10,15]],"date-time":"2014-10-15T10:09:48Z","timestamp":1413367788000},"page":"943-951","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Function and regulation of MTA1 and MTA3 in malignancies of the female reproductive system"],"prefix":"10.1007","volume":"33","author":[{"given":"Ansgar","family":"Br\u00fcning","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Blankenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"J\u00fcckstock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Mylonas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,16]]},"reference":[{"key":"9520_CR1","first-page":"69","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011). Global cancer statistics. CA: A Cancer Journal for Clinicians, 61, 69\u201390.","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"9520_CR2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10555-006-7886-9","volume":"25","author":"EI Deryugina","year":"2006","unstructured":"Deryugina, E. I., & Quigley, J. P. (2006). Matrix metalloproteinases and tumor metastasis. Cancer and Metastasis Reviews, 25, 9\u201334.","journal-title":"Cancer and Metastasis Reviews"},{"issue":"1\u20132","key":"9520_CR3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10555-008-9179-y","volume":"28","author":"O Schmalhofer","year":"2009","unstructured":"Schmalhofer, O., Brabletz, S., & Brabletz, T. (2009). E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer and Metastasis Reviews, 28(1\u20132), 151\u2013166.","journal-title":"Cancer and Metastasis Reviews"},{"issue":"1\u20132","key":"9520_CR4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10555-011-9344-6","volume":"31","author":"J Bastid","year":"2012","unstructured":"Bastid, J. (2012). EMT in carcinoma progression and dissemination: facts, unanswered questions, and clinical considerations. Cancer and Metastasis Reviews, 31(1\u20132), 277\u2013283.","journal-title":"Cancer and Metastasis Reviews"},{"issue":"3\u20134","key":"9520_CR5","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s10555-012-9379-3","volume":"31","author":"F Meng","year":"2012","unstructured":"Meng, F., & Wu, G. (2012). The rejuvenated scenario of epithelial-mesenchymal transition (EMT) and cancer metastasis. Cancer and Metastasis Reviews, 31(3\u20134), 455\u2013467.","journal-title":"Cancer and Metastasis Reviews"},{"key":"9520_CR6","doi-asserted-by":"crossref","first-page":"812","DOI":"10.4161\/cc.5.8.2646","volume":"5","author":"SY Wong","year":"2006","unstructured":"Wong, S. Y., & Hynes, R. O. (2006). Lymphatic or hematogenous dissemination: how does a metastatic tumor cell decide? Cell Cycle, 5, 812\u2013817.","journal-title":"Cell Cycle"},{"key":"9520_CR7","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/CCO.0b013e32833ea80c","volume":"22","author":"MA Tessel","year":"2010","unstructured":"Tessel, M. A., Krett, N. L., & Rosen, S. T. (2010). Steroid receptor and microRNA regulation in cancer. Current Opinion in Oncology, 22, 592\u2013597.","journal-title":"Current Opinion in Oncology"},{"issue":"3","key":"9520_CR8","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/jcb.20566","volume":"96","author":"RR Singh","year":"2005","unstructured":"Singh, R. R., & Kumar, R. (2005). Steroid hormone receptor signaling in tumorigenesis. Journal of Cellular Biochemistry, 96(3), 490\u2013505. doi: 10.1002\/jcb.20566 .","journal-title":"Journal of Cellular Biochemistry"},{"issue":"5","key":"9520_CR9","first-page":"369","volume":"5","author":"RJ Miksicek","year":"1994","unstructured":"Miksicek, R. J. (1994). Steroid receptor variants and their potential role in cancer. Seminars in Cancer Biology, 5(5), 369\u2013379.","journal-title":"Seminars in Cancer Biology"},{"issue":"3","key":"9520_CR10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10585-008-9233-8","volume":"26","author":"Y Toh","year":"2009","unstructured":"Toh, Y., & Nicolson, G. L. (2009). The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications. Clinical and Experimental Metastasis, 26(3), 215\u2013227.","journal-title":"Clinical and Experimental Metastasis"},{"issue":"2","key":"9520_CR11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1158\/0008-5472.CAN-11-2345","volume":"72","author":"DQ Li","year":"2012","unstructured":"Li, D. Q., Pakala, S. B., Nair, S. S., Eswaran, J., & Kumar, R. (2012). Metastasis-associated protein 1\/nucleosome remodeling and histone deacetylase complex in cancer. Cancer Research, 72(2), 387\u2013394.","journal-title":"Cancer Research"},{"key":"9520_CR12","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/sj.onc.1210839","volume":"27","author":"PR Molli","year":"2008","unstructured":"Molli, P. R., Singh, R. R., Lee, S. W., & Kumar, R. (2008). MTA1-mediated transcriptional repression of BRCA1 tumor suppressor gene. Oncogene, 27, 1971\u20131980.","journal-title":"Oncogene"},{"key":"9520_CR13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0092-8674(03)00234-4","volume":"113","author":"N Fujita","year":"2003","unstructured":"Fujita, N., Jaye, D. L., Kajita, M., Geigerman, C., Moreno, C. S., & Wade, P. A. (2003). MTA3, a Mi-2\/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell, 113, 207\u2013219.","journal-title":"Cell"},{"issue":"6","key":"9520_CR14","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.humpath.2006.01.024","volume":"37","author":"S Balasenthil","year":"2006","unstructured":"Balasenthil, S., Broaddus, R. R., & Kumar, R. (2006). Expression of metastasis-associated protein 1 (MTA1) in benign endometrium and endometrial adenocarcinomas. Human Pathology, 37(6), 656\u2013661. doi: 10.1016\/j.humpath.2006.01.024 .","journal-title":"Human Pathology"},{"issue":"1","key":"9520_CR15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00418-009-0595-z","volume":"132","author":"A Bruning","year":"2009","unstructured":"Bruning, A., Makovitzky, J., Gingelmaier, A., Friese, K., & Mylonas, I. (2009). The metastasis-associated genes MTA1 and MTA3 are abundantly expressed in human placenta and chorionic carcinoma cells. Histochemistry and Cell Biology, 132(1), 33\u201338. doi: 10.1007\/s00418-009-0595-z .","journal-title":"Histochemistry and Cell Biology"},{"issue":"6","key":"9520_CR16","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.tice.2009.04.002","volume":"41","author":"W Li","year":"2009","unstructured":"Li, W., Ma, L., Zhao, J., Liu, X., Li, Z., & Zhang, Y. (2009). Expression profile of MTA1 in adult mouse tissues. Tissue and Cell, 41(6), 390\u2013399. doi: 10.1016\/j.tice.2009.04.002 .","journal-title":"Tissue and Cell"},{"issue":"4","key":"9520_CR17","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.bbrc.2013.02.102","volume":"433","author":"Y Chen","year":"2013","unstructured":"Chen, Y., Miyazaki, J., Nishizawa, H., Kurahashi, H., Leach, R., & Wang, K. (2013). MTA3 regulates CGB5 and Snail genes in trophoblast. Biochemical and Biophysical Research Communications, 433(4), 379\u2013384. doi: 10.1016\/j.bbrc.2013.02.102 .","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"2\u20133","key":"9520_CR18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10911-007-9043-7","volume":"12","author":"RR Singh","year":"2007","unstructured":"Singh, R. R., & Kumar, R. (2007). MTA family of transcriptional metaregulators in mammary gland morphogenesis and breast cancer. Journal of Mammary Gland Biology and Neoplasia, 12(2\u20133), 115\u2013125. doi: 10.1007\/s10911-007-9043-7 .","journal-title":"Journal of Mammary Gland Biology and Neoplasia"},{"issue":"21","key":"9520_CR19","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1101\/gad.1461706","volume":"20","author":"H Zhang","year":"2006","unstructured":"Zhang, H., Singh, R. R., Talukder, A. H., & Kumar, R. (2006). Metastatic tumor antigen 3 is a direct corepressor of the Wnt4 pathway. Genes and Development, 20(21), 2943\u20132948. doi: 10.1101\/gad.1461706 .","journal-title":"Genes and Development"},{"issue":"1","key":"9520_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctrv.2007.08.007","volume":"34","author":"D Pectasides","year":"2008","unstructured":"Pectasides, D., Pectasides, E., & Psyrri, A. (2008). Granulosa cell tumor of the ovary. Cancer Treatment Reviews, 34(1), 1\u201312. doi: 10.1016\/j.ctrv.2007.08.007 .","journal-title":"Cancer Treatment Reviews"},{"issue":"5","key":"9520_CR21","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ctrv.2008.02.002","volume":"34","author":"D Pectasides","year":"2008","unstructured":"Pectasides, D., Pectasides, E., & Kassanos, D. (2008). Germ cell tumors of the ovary. Cancer Treatment Reviews, 34(5), 427\u2013441. doi: 10.1016\/j.ctrv.2008.02.002 .","journal-title":"Cancer Treatment Reviews"},{"issue":"7","key":"9520_CR22","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.humpath.2011.03.003","volume":"42","author":"RJ Kurman","year":"2011","unstructured":"Kurman, R. J., & Shih Ie, M. (2011). Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer\u2014shifting the paradigm. Human Pathology, 42(7), 918\u2013931. doi: 10.1016\/j.humpath.2011.03.003 .","journal-title":"Human Pathology"},{"key":"9520_CR23","unstructured":"International Agency for Research on Cancer, I. (2008). Descriptive Epidemiology Group of IARC (2008) GLOBOCAN 2002 database. http:\/\/www-dep.iarc.fr\/2 ."},{"issue":"3\u20134","key":"9520_CR24","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s10555-012-9383-7","volume":"31","author":"R Longuespee","year":"2012","unstructured":"Longuespee, R., Boyon, C., Desmons, A., Vinatier, D., Leblanc, E., Farre, I., et al. (2012). Ovarian cancer molecular pathology. Cancer and Metastasis Reviews, 31(3\u20134), 713\u2013732. doi: 10.1007\/s10555-012-9383-7 .","journal-title":"Cancer and Metastasis Reviews"},{"key":"9520_CR25","author":"B Thibault","year":"2013","unstructured":"Thibault, B., Castells, M., Delord, J. P., & Couderc, B. (2013). Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition. Cancer and Metastasis Reviews. doi: 10.1007\/s10555-013-9456-2 .","journal-title":"Cancer and Metastasis Reviews"},{"issue":"3","key":"9520_CR26","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrc2583","volume":"9","author":"TA Yap","year":"2009","unstructured":"Yap, T. A., Carden, C. P., & Kaye, S. B. (2009). Beyond chemotherapy: targeted therapies in ovarian cancer. Nature Reviews Cancer, 9(3), 167\u2013181. doi: 10.1038\/nrc2583 .","journal-title":"Nature Reviews Cancer"},{"issue":"2","key":"9520_CR27","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1053\/j.seminoncol.2008.12.003","volume":"36","author":"LP Martin","year":"2009","unstructured":"Martin, L. P., & Schilder, R. J. (2009). Management of recurrent ovarian carcinoma: current status and future directions. Seminar in Oncology, 36(2), 112\u2013125. doi: 10.1053\/j.seminoncol.2008.12.003 .","journal-title":"Seminar in Oncology"},{"issue":"5","key":"9520_CR28","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s00404-010-1757-x","volume":"283","author":"A Br\u00fcning","year":"2011","unstructured":"Br\u00fcning, A., & Mylonas, I. (2011). New emerging drugs targeting the genomic integrity and replication machinery in ovarian cancer. Archives of Gynecology and Obstetrics, 283(5), 1087\u20131096. doi: 10.1007\/s00404-010-1757-x .","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"Suppl 1","key":"9520_CR29","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0020-7292(03)90118-4","volume":"83","author":"AP Heintz","year":"2003","unstructured":"Heintz, A. P., Odicino, F., Maisonneuve, P., Beller, U., Benedet, J. L., Creasman, W. T., et al. (2003). Carcinoma of the ovary. International Journal of Gynaecology and Obstetrics, 83(Suppl 1), 135\u2013166.","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"7716","key":"9520_CR30","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(71)92335-X","volume":"2","author":"MF Fathalla","year":"1971","unstructured":"Fathalla, M. F. (1971). Incessant ovulation\u2014a factor in ovarian neoplasia? Lancet, 2(7716), 163.","journal-title":"Lancet"},{"issue":"2","key":"9520_CR31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00404-013-3041-3","volume":"289","author":"J Dietl","year":"2014","unstructured":"Dietl, J. (2014). Revisiting the pathogenesis of ovarian cancer: the central role of the fallopian tube. Archives of Gynecology and Obstetrics, 289(2), 241\u2013246. doi: 10.1007\/s00404-013-3041-3 .","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"2","key":"9520_CR32","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0090-8258(03)00365-2","volume":"90","author":"JM Piek","year":"2003","unstructured":"Piek, J. M., Verheijen, R. H., Kenemans, P., Massuger, L. F., Bulten, H., & van Diest, P. J. (2003). BRCA1\/2-related ovarian cancers are of tubal origin: a hypothesis. Gynecologic Oncology, 90(2), 491.","journal-title":"Gynecologic Oncology"},{"issue":"1","key":"9520_CR33","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ygyno.2013.03.021","volume":"130","author":"N Auersperg","year":"2013","unstructured":"Auersperg, N. (2013). Ovarian surface epithelium as a source of ovarian cancers: unwarranted speculation or evidence-based hypothesis? Gynecologic Oncology, 130(1), 246\u2013251. doi: 10.1016\/j.ygyno.2013.03.021 .","journal-title":"Gynecologic Oncology"},{"issue":"3","key":"9520_CR34","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1074\/jbc.R600029200","volume":"282","author":"B Manavathi","year":"2007","unstructured":"Manavathi, B., & Kumar, R. (2007). Metastasis tumor antigens, an emerging family of multifaceted master coregulators. Journal of Biological Chemistry, 282(3), 1529\u20131533. doi: 10.1074\/jbc.R600029200 .","journal-title":"Journal of Biological Chemistry"},{"issue":"9","key":"9520_CR35","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.4161\/cbt.7.9.6427","volume":"7","author":"C Dannenmann","year":"2008","unstructured":"Dannenmann, C., Shabani, N., Friese, K., Jeschke, U., Mylonas, I., & Bruning, A. (2008). The metastasis-associated gene MTA1 is upregulated in advanced ovarian cancer, represses ERbeta, and enhances expression of oncogenic cytokine GRO. Cancer Biology and Therapy, 7(9), 1460\u20131467.","journal-title":"Cancer Biology and Therapy"},{"issue":"2","key":"9520_CR36","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.humpath.2011.05.002","volume":"43","author":"MG Prisco","year":"2012","unstructured":"Prisco, M. G., Zannoni, G. F., De Stefano, I., Vellone, V. G., Tortorella, L., Fagotti, A., et al. (2012). Prognostic role of metastasis tumor antigen 1 in patients with ovarian cancer: a clinical study. Human Pathology, 43(2), 282\u2013288. doi: 10.1016\/j.humpath.2011.05.002 .","journal-title":"Human Pathology"},{"issue":"4","key":"9520_CR37","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1007\/s13277-013-0797-9","volume":"34","author":"R Bhagat","year":"2013","unstructured":"Bhagat, R., Premalata, C. S., Shilpa, V., Pallavi, V. R., Ramesh, G., Vijay, C. R., et al. (2013). Altered expression of beta-catenin, E-cadherin, and E-cadherin promoter methylation in epithelial ovarian carcinoma. Tumour Biology, 34(4), 2459\u20132468. doi: 10.1007\/s13277-013-0797-9 .","journal-title":"Tumour Biology"},{"issue":"1","key":"9520_CR38","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/excr.1994.1320","volume":"215","author":"PA Kruk","year":"1994","unstructured":"Kruk, P. A., Uitto, V. J., Firth, J. D., Dedhar, S., & Auersperg, N. (1994). Reciprocal interactions between human ovarian surface epithelial cells and adjacent extracellular matrix. Experimental Cell Research, 215(1), 97\u2013108. doi: 10.1006\/excr.1994.1320 .","journal-title":"Experimental Cell Research"},{"issue":"3","key":"9520_CR39","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/jcp.21240","volume":"213","author":"N Ahmed","year":"2007","unstructured":"Ahmed, N., Thompson, E. W., & Quinn, M. A. (2007). Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: an exception to the norm. Journal of Cellular Physiology, 213(3), 581\u2013588. doi: 10.1002\/jcp.21240 .","journal-title":"Journal of Cellular Physiology"},{"issue":"39","key":"9520_CR40","doi-asserted-by":"crossref","first-page":"13968","DOI":"10.1073\/pnas.0502330102","volume":"102","author":"XY Zhang","year":"2005","unstructured":"Zhang, X. Y., DeSalle, L. M., Patel, J. H., Capobianco, A. J., Yu, D., Thomas-Tikhonenko, A., et al. (2005). Metastasis-associated protein 1 (MTA1) is an essential downstream effector of the c-MYC oncoprotein. Proceedings of the National Academy of Sciences of the United States of America, 102(39), 13968\u201313973. doi: 10.1073\/pnas.0502330102 .","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"9520_CR41","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ejca.2005.11.022","volume":"42","author":"I Dimova","year":"2006","unstructured":"Dimova, I., Raitcheva, S., Dimitrov, R., Doganov, N., & Toncheva, D. (2006). Correlations between c-myc gene copy-number and clinicopathological parameters of ovarian tumours. European Journal of Cancer, 42(5), 674\u2013679. doi: 10.1016\/j.ejca.2005.11.022 .","journal-title":"European Journal of Cancer"},{"issue":"1","key":"9520_CR42","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/35050532","volume":"3","author":"A Mazumdar","year":"2001","unstructured":"Mazumdar, A., Wang, R. A., Mishra, S. K., Adam, L., Bagheri-Yarmand, R., Mandal, M., et al. (2001). Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor. Nature Cell Biology, 3(1), 30\u201337. doi: 10.1038\/35050532 .","journal-title":"Nature Cell Biology"},{"issue":"8","key":"9520_CR43","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/bjc.2011.62","volume":"104","author":"Q Sheng","year":"2011","unstructured":"Sheng, Q., & Liu, J. (2011). The therapeutic potential of targeting the EGFR family in epithelial ovarian cancer. British Journal of Cancer, 104(8), 1241\u20131245. doi: 10.1038\/bjc.2011.62 .","journal-title":"British Journal of Cancer"},{"issue":"10","key":"9520_CR44","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s00204-012-0868-5","volume":"86","author":"KA Burns","year":"2012","unstructured":"Burns, K. A., & Korach, K. S. (2012). Estrogen receptors and human disease: an update. Archives of Toxicology, 86(10), 1491\u20131504. doi: 10.1007\/s00204-012-0868-5 .","journal-title":"Archives of Toxicology"},{"issue":"3","key":"9520_CR45","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.ygyno.2012.09.006","volume":"127","author":"J Haring","year":"2012","unstructured":"Haring, J., Schuler, S., Lattrich, C., Ortmann, O., & Treeck, O. (2012). Role of estrogen receptor beta in gynecological cancer. Gynecologic Oncology, 127(3), 673\u2013676. doi: 10.1016\/j.ygyno.2012.09.006 .","journal-title":"Gynecologic Oncology"},{"key":"9520_CR46","author":"X He","year":"2013","unstructured":"He, X., Zhou, C., Zheng, L., & Xiong, Z. (2013). Overexpression of MTA1 promotes invasiveness and metastasis of ovarian cancer cells. Irish Journal of Medical Science. doi: 10.1007\/s11845-013-1034-7 .","journal-title":"Irish Journal of Medical Science"},{"issue":"12","key":"9520_CR47","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1158\/0008-5472.CAN-12-3998","volume":"73","author":"SB Pakala","year":"2013","unstructured":"Pakala, S. B., Rayala, S. K., Wang, R. A., Ohshiro, K., Mudvari, P., Reddy, S. D., et al. (2013). MTA1 promotes STAT3 transcription and pulmonary metastasis in breast cancer. Cancer Research, 73(12), 3761\u20133770. doi: 10.1158\/0008-5472.CAN-12-3998 .","journal-title":"Cancer Research"},{"issue":"11","key":"9520_CR48","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1002\/cncr.22293","volume":"107","author":"DG Rosen","year":"2006","unstructured":"Rosen, D. G., Mercado-Uribe, I., Yang, G., Bast, R. C., Jr., Amin, H. M., Lai, R., et al. (2006). The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis. Cancer, 107(11), 2730\u20132740. doi: 10.1002\/cncr.22293 .","journal-title":"Cancer"},{"issue":"1","key":"9520_CR49","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/sj.bjc.6604794","volume":"100","author":"M Colomiere","year":"2009","unstructured":"Colomiere, M., Ward, A. C., Riley, C., Trenerry, M. K., Cameron-Smith, D., Findlay, J., et al. (2009). Cross talk of signals between EGFR and IL-6R through JAK2\/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas. British Journal of Cancer, 100(1), 134\u2013144. doi: 10.1038\/sj.bjc.6604794 .","journal-title":"British Journal of Cancer"},{"key":"9520_CR50","doi-asserted-by":"crossref","first-page":"421821","DOI":"10.1155\/2013\/421821","volume":"2013","author":"MZ Kamran","year":"2013","unstructured":"Kamran, M. Z., Patil, P., & Gude, R. P. (2013). Role of STAT3 in cancer metastasis and translational advances. Biomedical Research International, 2013, 421821. doi: 10.1155\/2013\/421821 .","journal-title":"Biomedical Research International"},{"issue":"7","key":"9520_CR51","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.cell.2004.06.006","volume":"117","author":"J Yang","year":"2004","unstructured":"Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., et al. (2004). Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell, 117(7), 927\u2013939. doi: 10.1016\/j.cell.2004.06.006 .","journal-title":"Cell"},{"issue":"12","key":"9520_CR52","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1002\/1097-0142(19910615)67:12<3093::AID-CNCR2820671226>3.0.CO;2-L","volume":"67","author":"VM Abeler","year":"1991","unstructured":"Abeler, V. M., & Kjorstad, K. E. (1991). Endometrial adenocarcinoma in Norway. A study of a total population. Cancer, 67(12), 3093\u20133103.","journal-title":"Cancer"},{"issue":"9484","key":"9520_CR53","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0140-6736(05)67063-8","volume":"366","author":"F Amant","year":"2005","unstructured":"Amant, F., Moerman, P., Neven, P., Timmerman, D., Van Limbergen, E., & Vergote, I. (2005). Endometrial cancer. Lancet, 366(9484), 491\u2013505.","journal-title":"Lancet"},{"issue":"2","key":"9520_CR54","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ygyno.2007.05.033","volume":"106","author":"JK Chan","year":"2007","unstructured":"Chan, J. K., Wu, H., Cheung, M. K., Shin, J. Y., Osann, K., & Kapp, D. S. (2007). The outcomes of 27,063 women with unstaged endometrioid uterine cancer. Gynecologic Oncology, 106(2), 282\u2013288. doi: 10.1016\/j.ygyno.2007.05.033 .","journal-title":"Gynecologic Oncology"},{"issue":"6","key":"9520_CR55","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.humpath.2004.02.007","volume":"35","author":"J Prat","year":"2004","unstructured":"Prat, J. (2004). Prognostic parameters of endometrial carcinoma. Human Pathology, 35(6), 649\u2013662.","journal-title":"Human Pathology"},{"issue":"6","key":"9520_CR56","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1634\/theoncologist.8-6-541","volume":"8","author":"LA Gloeckler Ries","year":"2003","unstructured":"Gloeckler Ries, L. A., Reichman, M. E., Lewis, D. R., Hankey, B. F., & Edwards, B. K. (2003). Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program. The Oncologist, 8(6), 541\u2013552.","journal-title":"The Oncologist"},{"issue":"9823","key":"9520_CR57","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S0140-6736(12)60442-5","volume":"379","author":"JD Wright","year":"2012","unstructured":"Wright, J. D., Barrena Medel, N. I., Sehouli, J., Fujiwara, K., & Herzog, T. J. (2012). Contemporary management of endometrial cancer. Lancet, 379(9823), 1352\u20131360. doi: 10.1016\/S0140-6736(12)60442-5 .","journal-title":"Lancet"},{"issue":"5","key":"9520_CR58","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1097\/AOG.0b013e31826bb121","volume":"120","author":"CL Trimble","year":"2012","unstructured":"Trimble, C. L., Method, M., Leitao, M., Lu, K., Ioffe, O., Hampton, M., et al. (2012). Management of endometrial precancers. Obstetrics and Gynecology, 120(5), 1160\u20131175. doi: 10.1097\/AOG.0b013e31826bb121 .","journal-title":"Obstetrics and Gynecology"},{"issue":"3\u20134","key":"9520_CR59","first-page":"237","volume":"10","author":"L Deligdisch","year":"1987","unstructured":"Deligdisch, L., & Holinka, C. F. (1987). Endometrial carcinoma: two diseases? Cancer Detection and Prevention, 10(3\u20134), 237\u2013246.","journal-title":"Cancer Detection and Prevention"},{"issue":"1","key":"9520_CR60","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","volume":"15","author":"JV Bokhman","year":"1983","unstructured":"Bokhman, J. V. (1983). Two pathogenetic types of endometrial carcinoma. Gynecologic Oncology, 15(1), 10\u201317.","journal-title":"Gynecologic Oncology"},{"issue":"3","key":"9520_CR61","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00428-003-0947-3","volume":"444","author":"SF Lax","year":"2004","unstructured":"Lax, S. F. (2004). Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification. Virchows Archiv, 444(3), 213\u2013223.","journal-title":"Virchows Archiv"},{"issue":"4","key":"9520_CR62","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1525-1438.1999.99038.x","volume":"9","author":"B Jereczek-Fossa","year":"1999","unstructured":"Jereczek-Fossa, B., Badzio, A., & Jassem, J. (1999). Surgery followed by radiotherapy in endometrial cancer: analysis of survival and patterns of failure. International Journal of Gynecological Cancer, 9(4), 285\u2013294.","journal-title":"International Journal of Gynecological Cancer"},{"issue":"3","key":"9520_CR63","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/j.1525-1438.2006.00576.x","volume":"16","author":"D Faratian","year":"2006","unstructured":"Faratian, D., Stillie, A., Busby-Earle, R. M., Cowie, V. J., & Monaghan, H. (2006). A review of the pathology and management of uterine papillary serous carcinoma and correlation with outcome. International Journal of Gynecological Cancer, 16(3), 972\u2013978.","journal-title":"International Journal of Gynecological Cancer"},{"key":"9520_CR64","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s007610050373","volume":"5","author":"G Dallenbach-Hellweg","year":"1999","unstructured":"Dallenbach-Hellweg, G. (1999). Histopathologie und Stadieneinteilung des Endometriumkarzinoms inklusive seiner Pr\u00e4kanzerosen. Der Onkologe, 5, 388\u2013395.","journal-title":"Der Onkologe"},{"issue":"5","key":"9520_CR65","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1048-891X.2004.14533.x","volume":"14","author":"N Macwhinnie","year":"2004","unstructured":"Macwhinnie, N., & Monaghan, H. (2004). The use of P53, PTEN, and C-erbB-2 to differentiate uterine serous papillary carcinoma from endometrioid endometrial carcinoma. International Journal of Gynecological Cancer, 14(5), 938\u2013946.","journal-title":"International Journal of Gynecological Cancer"},{"issue":"5","key":"9520_CR66","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1111\/j.1525-1438.2006.00664.x","volume":"16","author":"JA Villella","year":"2006","unstructured":"Villella, J. A., Cohen, S., Smith, D. H., Hibshoosh, H., & Hershman, D. (2006). HER-2\/neu overexpression in uterine papillary serous cancers and its possible therapeutic implications. International Journal of Gynecological Cancer, 16(5), 1897\u20131902.","journal-title":"International Journal of Gynecological Cancer"},{"issue":"1","key":"9520_CR67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejogrb.2013.01.018","volume":"169","author":"P Tsikouras","year":"2013","unstructured":"Tsikouras, P., Bouchlariotou, S., Vrachnis, N., Dafopoulos, A., Galazios, G., Csorba, R., et al. (2013). Endometrial cancer: molecular and therapeutic aspects. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 169(1), 1\u20139. doi: 10.1016\/j.ejogrb.2013.01.018 .","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"issue":"13","key":"9520_CR68","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/j.ejca.2010.06.001","volume":"46","author":"I Mylonas","year":"2010","unstructured":"Mylonas, I. (2010). Inhibin-alpha, -betaA and -betaB subunits in uterine non-endometrioid carcinomas: prognostic significance and clinical implications. European Journal of Cancer, 46(13), 2485\u20132493. doi: 10.1016\/j.ejca.2010.06.001 .","journal-title":"European Journal of Cancer"},{"issue":"7","key":"9520_CR69","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.ejca.2009.01.008","volume":"45","author":"I Mylonas","year":"2009","unstructured":"Mylonas, I., Worbs, S., Shabani, N., Kuhn, C., Kunze, S., Schulze, S., et al. (2009). Inhibin-alpha subunit is an independent prognostic parameter in human endometrial carcinomas: analysis of inhibin\/activin-alpha, -betaA and -betaB subunits in 302 cases. European Journal of Cancer, 45(7), 1304\u20131314. doi: 10.1016\/j.ejca.2009.01.008 .","journal-title":"European Journal of Cancer"},{"issue":"16","key":"9520_CR70","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/j.ejca.2007.08.014","volume":"43","author":"N Shabani","year":"2007","unstructured":"Shabani, N., Kuhn, C., Kunze, S., Schulze, S., Mayr, D., Dian, D., et al. (2007). Prognostic significance of oestrogen receptor alpha (ERalpha) and beta (ERbeta), progesterone receptor A (PR-A) and B (PR-B) in endometrial carcinomas. European Journal of Cancer, 43(16), 2434\u20132444. doi: 10.1016\/j.ejca.2007.08.014 .","journal-title":"European Journal of Cancer"},{"issue":"10","key":"9520_CR71","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.humpath.2013.04.009","volume":"44","author":"C Mirantes","year":"2013","unstructured":"Mirantes, C., Espinosa, I., Ferrer, I., Dolcet, X., Prat, J., & Matias-Guiu, X. (2013). Epithelial-to-mesenchymal transition and stem cells in endometrial cancer. Human Pathology, 44(10), 1973\u20131981. doi: 10.1016\/j.humpath.2013.04.009 .","journal-title":"Human Pathology"},{"issue":"4","key":"9520_CR72","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/PDM.0b013e31806219ae","volume":"16","author":"K Blechschmidt","year":"2007","unstructured":"Blechschmidt, K., Kremmer, E., Hollweck, R., Mylonas, I., Hofler, H., Kremer, M., et al. (2007). The E-cadherin repressor snail plays a role in tumor progression of endometrioid adenocarcinomas. Diagnostic Molecular Pathology, 16(4), 222\u2013228. doi: 10.1097\/PDM.0b013e31806219ae .","journal-title":"Diagnostic Molecular Pathology"},{"issue":"11","key":"9520_CR73","first-page":"1447","volume":"25","author":"A Bruning","year":"2010","unstructured":"Bruning, A., Juckstock, J., Blankenstein, T., Makovitzky, J., Kunze, S., & Mylonas, I. (2010). The metastasis-associated gene MTA3 is downregulated in advanced endometrioid adenocarcinomas. Histology and Histopathology, 25(11), 1447\u20131456.","journal-title":"Histology and Histopathology"},{"issue":"4","key":"9520_CR74","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1365-2559.2011.04103.x","volume":"60","author":"I Mylonas","year":"2012","unstructured":"Mylonas, I., & Bruning, A. (2012). The metastasis-associated gene MTA3 is an independent prognostic parameter in uterine non-endometrioid carcinomas. Histopathology, 60(4), 665\u2013670. doi: 10.1111\/j.1365-2559.2011.04103.x .","journal-title":"Histopathology"},{"issue":"5","key":"9520_CR75","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/00130404-200309000-00004","volume":"9","author":"EL Franco","year":"2003","unstructured":"Franco, E. L., Schlecht, N. F., & Saslow, D. (2003). The epidemiology of cervical cancer. Cancer Journal, 9(5), 348\u2013359.","journal-title":"Cancer Journal"},{"issue":"9376","key":"9520_CR76","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1016\/S0140-6736(03)13778-6","volume":"361","author":"SE Waggoner","year":"2003","unstructured":"Waggoner, S. E. (2003). Cervical cancer. Lancet, 361(9376), 2217\u20132225. doi: 10.1016\/S0140-6736(03)13778-6 .","journal-title":"Lancet"},{"issue":"1","key":"9520_CR77","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/CCO.0000000000000034","volume":"26","author":"KM Elfstrom","year":"2014","unstructured":"Elfstrom, K. M., Herweijer, E., Sundstrom, K., & Arnheim-Dahlstrom, L. (2014). Current cervical cancer prevention strategies including cervical screening and prophylactic human papillomavirus vaccination: a review. Current Opinion in Oncology, 26(1), 120\u2013129. doi: 10.1097\/CCO.0000000000000034 .","journal-title":"Current Opinion in Oncology"},{"issue":"1","key":"9520_CR78","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ygyno.2009.09.040","volume":"116","author":"LT Gien","year":"2010","unstructured":"Gien, L. T., Beauchemin, M. C., & Thomas, G. (2010). Adenocarcinoma: a unique cervical cancer. Gynecologic Oncology, 116(1), 140\u2013146. doi: 10.1016\/j.ygyno.2009.09.040 .","journal-title":"Gynecologic Oncology"},{"issue":"6","key":"9520_CR79","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N Munoz","year":"2003","unstructured":"Munoz, N., Bosch, F. X., de Sanjose, S., Herrero, R., Castellsague, X., Shah, K. V., et al. (2003). Epidemiologic classification of human papillomavirus types associated with cervical cancer. New England Journal of Medicine, 348(6), 518\u2013527. doi: 10.1056\/NEJMoa021641 .","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"9520_CR80","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ygyno.2009.04.005","volume":"114","author":"LS Massad","year":"2009","unstructured":"Massad, L. S., Einstein, M., Myers, E., Wheeler, C. M., Wentzensen, N., & Solomon, D. (2009). The impact of human papillomavirus vaccination on cervical cancer prevention efforts. Gynecologic Oncology, 114(2), 360\u2013364. doi: 10.1016\/j.ygyno.2009.04.005 .","journal-title":"Gynecologic Oncology"},{"issue":"2","key":"9520_CR81","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.virol.2008.11.046","volume":"384","author":"H Hausen zur","year":"2009","unstructured":"zur Hausen, H. (2009). Papillomaviruses in the causation of human cancers\u2014a brief historical account. Virology, 384(2), 260\u2013265. doi: 10.1016\/j.virol.2008.11.046 .","journal-title":"Virology"},{"issue":"1","key":"9520_CR82","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers, J. M., Jacobs, M. V., Manos, M. M., Bosch, F. X., Kummer, J. A., Shah, K. V., et al. (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. Journal of Pathology, 189(1), 12\u201319. doi: 10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F .","journal-title":"Journal of Pathology"},{"issue":"8","key":"9520_CR83","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/onc.2009.404","volume":"29","author":"TM Bui-Nguyen","year":"2010","unstructured":"Bui-Nguyen, T. M., Pakala, S. B., Sirigiri, R. D., Xia, W., Hung, M. C., Sarin, S. K., et al. (2010). NF-kappaB signaling mediates the induction of MTA1 by hepatitis B virus transactivator protein HBx. Oncogene, 29(8), 1179\u20131189. doi: 10.1038\/onc.2009.404 .","journal-title":"Oncogene"},{"issue":"1","key":"9520_CR84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11596-011-0141-9","volume":"31","author":"Y Rao","year":"2011","unstructured":"Rao, Y., Wang, H., Fan, L., & Chen, G. (2011). Silencing MTA1 by RNAi reverses adhesion, migration and invasiveness of cervical cancer cells (SiHa) via altered expression of p53, and E-cadherin\/beta-catenin complex. Journal of Huazhong University of Science and Technology. Medical Sciences, 31(1), 1\u20139. doi: 10.1007\/s11596-011-0141-9 .","journal-title":"Journal of Huazhong University of Science and Technology. Medical Sciences"},{"issue":"10","key":"9520_CR85","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/j.humpath.2013.05.009","volume":"44","author":"T Liu","year":"2013","unstructured":"Liu, T., Yang, M., Yang, S., Ge, T., Gu, L., & Lou, G. (2013). Metastasis-associated protein 1 is a novel marker predicting survival and lymph nodes metastasis in cervical cancer. Human Pathology, 44(10), 2275\u20132281. doi: 10.1016\/j.humpath.2013.05.009 .","journal-title":"Human Pathology"},{"issue":"10","key":"9520_CR86","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1042\/BC20060130","volume":"99","author":"H Qian","year":"2007","unstructured":"Qian, H., Yu, J., Li, Y., Wang, H., Song, C., Zhang, X., et al. (2007). RNA interference of metastasis-associated gene 1 inhibits metastasis of B16F10 melanoma cells in a C57BL\/6 mouse model. Biology of the Cell, 99(10), 573\u2013581.","journal-title":"Biology of the Cell"},{"issue":"9","key":"9520_CR87","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3748\/wjg.v17.i9.1219","volume":"17","author":"B Du","year":"2011","unstructured":"Du, B., Yang, Z. Y., Zhong, X. Y., Fang, M., Yan, Y. R., Qi, G. L., et al. (2011). Metastasis-associated protein 1 induces VEGF-C and facilitates lymphangiogenesis in colorectal cancer. World Journal of Gastroenterology, 17(9), 1219\u20131226. doi: 10.3748\/wjg.v17.i9.1219 .","journal-title":"World Journal of Gastroenterology"},{"key":"9520_CR88","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1756-9966-30-60","volume":"30","author":"Q Jiang","year":"2011","unstructured":"Jiang, Q., Zhang, H., & Zhang, P. (2011). ShRNA-mediated gene silencing of MTA1 influenced on protein expression of ER alpha, MMP-9, CyclinD1 and invasiveness, proliferation in breast cancer cell lines MDA-MB-231 and MCF-7 in vitro. Journal of Experimental & Clinical Cancer Research, 30, 60. doi: 10.1186\/1756-9966-30-60 .","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"key":"9520_CR89","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1756-9966-32-33","volume":"32","author":"Y Li","year":"2013","unstructured":"Li, Y., Chao, Y., Fang, Y., Wang, J., Wang, M., Zhang, H., et al. (2013). MTA1 promotes the invasion and migration of non-small cell lung cancer cells by downregulating miR-125b. Journal of Experimental & Clinical Cancer Research, 32, 33. doi: 10.1186\/1756-9966-32-33 .","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"issue":"14","key":"9520_CR90","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1158\/0008-5472.CAN-09-0898","volume":"69","author":"SD Reddy","year":"2009","unstructured":"Reddy, S. D., Pakala, S. B., Ohshiro, K., Rayala, S. K., & Kumar, R. (2009). MicroRNA-661, a c\/EBPalpha target, inhibits metastatic tumor antigen 1 and regulates its functions. Cancer Research, 69(14), 5639\u20135642. doi: 10.1158\/0008-5472.CAN-09-0898 .","journal-title":"Cancer Research"},{"issue":"3","key":"9520_CR91","first-page":"807","volume":"27","author":"H Zhou","year":"2012","unstructured":"Zhou, H., Xu, X., Xun, Q., Yu, D., Ling, J., Guo, F., et al. (2012). microRNA-30c negatively regulates endometrial cancer cells by targeting metastasis-associated gene-1. Oncology Reports, 27(3), 807\u2013812. doi: 10.3892\/or.2011.1574 .","journal-title":"Oncology Reports"},{"issue":"2","key":"9520_CR92","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.gene.2013.03.137","volume":"525","author":"T Wirth","year":"2013","unstructured":"Wirth, T., Parker, N., & Yla-Herttuala, S. (2013). History of gene therapy. Gene, 525(2), 162\u2013169. doi: 10.1016\/j.gene.2013.03.137 .","journal-title":"Gene"},{"issue":"1\u20132","key":"9520_CR93","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijpharm.2013.11.041","volume":"459","author":"D Ibraheem","year":"2014","unstructured":"Ibraheem, D., Elaissari, A., & Fessi, H. (2014). Gene therapy and DNA delivery systems. International Journal of Pharmaceutics, 459(1\u20132), 70\u201383. doi: 10.1016\/j.ijpharm.2013.11.041 .","journal-title":"International Journal of Pharmaceutics"},{"issue":"7","key":"9520_CR94","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/ijc.24928","volume":"126","author":"L Kai","year":"2010","unstructured":"Kai, L., Samuel, S. K., & Levenson, A. S. (2010). Resveratrol enhances p53 acetylation and apoptosis in prostate cancer by inhibiting MTA1\/NuRD complex. International Journal of Cancer, 126(7), 1538\u20131548. doi: 10.1002\/ijc.24928 .","journal-title":"International Journal of Cancer"},{"issue":"3","key":"9520_CR95","doi-asserted-by":"crossref","first-page":"e57542","DOI":"10.1371\/journal.pone.0057542","volume":"8","author":"K Li","year":"2013","unstructured":"Li, K., Dias, S. J., Rimando, A. M., Dhar, S., Mizuno, C. S., Penman, A. D., et al. (2013). Pterostilbene acts through metastasis-associated protein 1 to inhibit tumor growth, progression and metastasis in prostate cancer. PLoS ONE, 8(3), e57542. doi: 10.1371\/journal.pone.0057542 .","journal-title":"PLoS ONE"},{"key":"9520_CR96","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/nyas.12205","volume":"1290","author":"A Gescher","year":"2013","unstructured":"Gescher, A., Steward, W. P., & Brown, K. (2013). Resveratrol in the management of human cancer: how strong is the clinical evidence? Annals of the New York Academy of Sciences, 1290, 12\u201320. doi: 10.1111\/nyas.12205 .","journal-title":"Annals of the New York Academy of Sciences"},{"key":"9520_CR97","author":"R Benedetti","year":"2014","unstructured":"Benedetti, R., Conte, M., & Altucci, L. (2014). Targeting histone deacetylases in diseases: where are we? Antioxidants and Redox Signaling. doi: 10.1089\/ars.2013.5776 .","journal-title":"Antioxidants and Redox Signaling"},{"issue":"1","key":"9520_CR98","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molcel.2013.05.020","volume":"51","author":"CJ Millard","year":"2013","unstructured":"Millard, C. J., Watson, P. J., Celardo, I., Gordiyenko, Y., Cowley, S. M., Robinson, C. V., Fairall, L., & Schwabe, J. W. (2013). Class I HDACs share a common mechanism of regulation by inositol phosphates. Molecular Cell, 51(1), 57\u201367.","journal-title":"Molecular Cell"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-014-9520-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10555-014-9520-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-014-9520-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T22:55:27Z","timestamp":1717455327000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10555-014-9520-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,16]]},"references-count":98,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["9520"],"URL":"https:\/\/doi.org\/10.1007\/s10555-014-9520-6","relation":{},"ISSN":["0167-7659","1573-7233"],"issn-type":[{"value":"0167-7659","type":"print"},{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,16]]}}}